BioSpace News Archive

Research has estimated that up to 1 billion people around the world are affected by insufficient selenium intake.

TRANSGENE (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces that it will host a virtual Key Opinion Leader (KOL) event on Wednesday, April 19, 2023 at 12:00 pm ET / 6:00 pm CET.

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, and Korean non profit research institute Institut Pasteur Korea announced that they have jointly developed new lead compounds effective in treating resistant tuberculosis (TB).

Sorrento Therapeutics, Inc. announced that the U.S. Bankruptcy Court for the Southern District of Texas entered an order requiring the top 25 brokers, dealers, banks, and other nominees that act as agents for Sorrento shareholders to provide Sorrento with information related to the common stock of Scilex Holding Company, in connection with Sorrento’s chapter 11 case that was filed on February 13, 2023.

Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, announced Jeanine O’Kane as President of Syneos Health Communications — a portfolio of agencies spanning advertising, public relations, patient advocacy, medical communications, managed markets, and naming and branding.

InflaRx N.V. (Nasdaq: IFRX) today announced that Gohibic (vilobelimab), a first-in-class monoclonal anti-human complement factor C5a antibody, has been granted an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the treatment of coronavirus disease 19 (COVID-19) in hospitalized adults when initiated within 48 hours of receiving invasive mechanical ventilation (IMV), or extracorporeal membrane oxygenation (ECMO).

Namida Lab, a global pioneering tear-based cancer screening, unveiled Auria®, the groundbreaking at-home biological breast cancer screening test, at the New Technology Showcase during the 32nd Annual Interdisciplinary Breast Center Conference (NCoBC) in Las Vegas.

X4 Pharmaceuticals, a leader in the discovery and development of novel small-molecule therapeutics to benefit people with diseases of the immune system, announced that, effective on March 31, 2023, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan.

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) today announced that management will present at the Diamond Equity Research Emerging Growth Invitational virtual investor conference taking place Wednesday, April 5th.

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it will report first quarter 2023 financial results on Thursday, April 27, 2023, before the market opens.